Mrv0541 07091408032D          

 18 20  0  0  0  0            999 V2000
    0.2568  -26.4415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2568  -27.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4444  -27.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1869  -27.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1869  -26.4415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4444  -26.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0406  -26.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5356  -26.8540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0406  -27.5140    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4444  -25.2040    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8569  -24.5027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0319  -24.5027    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6843  -24.0931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3846  -24.5013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0896  -24.0982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7857  -24.5038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0896  -23.2732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4927  -24.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  2  9  1  0  0  0  0
 10  6  1  6  0  0  0
 11 12  1  0  0  0  0
 11 10  1  0  0  0  0
 12 10  1  0  0  0  0
 12 13  1  1  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
> <ID>
CHEBI:79042

> <NAME>
tasimelteon

> <DEFINITION>
A member of the class of 1-benzofurans that is propionamide in which one of the amide hydrogens is replaced by a [(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl group. A melatonin receptor agonist used for the treatment of non-24-hour sleep-wake disorder.

> <STAR>
3

> <SYNONYM>
VEC-162; VEC 162; BMS-214778; BMS 214778

> <IUPAC_NAME>
N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide

> <INN>
tasimelteonum; tasimelteon; tasimelteon; tasimelteon

> <BRAND_NAME>
Hetlioz

> <FORMULA>
C15H19NO2

> <MASS>
245.31690

> <MONOISOTOPIC_MASS>
245.14158

> <CHARGE>
0

> <SMILES>
CCC(=O)NC[C@@H]1C[C@H]1c1cccc2OCCc12

> <INCHI>
InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1

> <INCHIKEY>
PTOIAAWZLUQTIO-GXFFZTMASA-N

> <CAS_REGISTRY_NUMBER>
609799-22-6

> <REAXYS_REGISTRY_NUMBER>
15439325

> <CHEMIDPLUS>
609799-22-6

> <KEGG_DRUG_ACCESSION>
D09388

> <WIKIPEDIA_ACCESSION>
Tasimelteon

> <PUBMED_CITATION>
12661062; 19054552; 19579175; 21548834; 22680635; 22916799; 24228714; 24534583; 24610704; 24757362; 24759294; 24892896; 24958945

$$$$